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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A414and control group. RT-PCR revealed that the control group and the co-
culture groups have very different synthetic and catabolic activities. For
anabolic gene expression, the presence of macrophages caused the
chondrocytes to upregulate the expression of collagen type II, aggrecan,
COMP and SOX-9, albeit to different extents for the different groups. By
day 7, the LhCGþMfþþ showedmarked upregulation in the expression
for all the anabolic genes; the LhCGþMf_group only showed increased
expression for collagen type II and COMP by day 14. Similarly, both the
co-culture groups showed upregulation of catabolic genes such asMMP-
1 and MMP-3, while the expression levels of these two genes remained
signiﬁcantly low in the control group. Additionally, the aggrecan content
in the LhCGþMfþþ groupwas consistently the lowest among the three
groups throughout the 14-days of studies. Moreover, only the LhCG þ
Mfþþ group showed a decrease in the total collagen content by day 14.
The occurrence of cartilagematrix degradationwas further conﬁrmed by
the results of histological and immunohistochemical staining, which
revealed that degradation of collagen type II and proteoglycan, while
occurring in both the co-culture groups, was especially evident in the
LhCGþMfþþ group. Also, hypertrophy and apoptosis of chondrocytes
was most prominently observed in the LhCGþMfþþ group.
Conclusions: The results demonstrated that the two phases of cartilage
degeneration in OA, namely the biosynthetic and degradative phase,
have taken place. Therefore, this newly established cartilage tissue
model has shown good promise to be developed as an accurate in vitro
3D model for future anti-osteoarthritic drug testing. (Reference: Peck,
Y., Ng, L. Y., Goh, J. Y. L, Gao, C. Y., Wang, D. A.*, “A three-dimensionally
engineered biomimetic cartilaginous tissue model for osteoarthritic
drug evaluation”, Molecular Pharmaceutics, 11 (2014), 7: 1997-2008.)
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DEVELOPMENT OF A TISSUE-ENGINEERED CONSTRUCT FOR BONE
REPAIR
S. Sadasivan, G. Shaw, M. Murphy, F. Barry. Natl. Univ. of Ireland, Galway,
Galway, Ireland
Purpose: The task of repairing large sections of bone tissue lost due to
major trauma or pathology poses a signiﬁcant challenge in orthopaedic
healthcare. The medical intervention often resorted to consists of a
combination of grafting procedures, internal and external prostheses
and ﬁxation devices. A promising strategy is to employ methods that
will lead to the restoration of functional bone tissue. The objective of
this research project is to develop a combination product consisting of a
tissue engineered construct and a device to provide mechanical sup-
port, restore the vascular supply and regenerate the bone tissue. The
tissue engineering component involves the use of mesenchymal stem
cells in an osteoconductive hydroxyapatite tricalcium phosphate (HA/
TCP) scaffold to stimulate revascularisation of new bone. The device
component involves employing a developmental device to provide
mechanical support and prevent tissue collapse.
Methods: A biphasic scaffold consisting of 3mm cubes of hydrox-
yapatite (HA) (75 %) and Tricalcium Phosphate (TCP) (25%) (Biosel,
DePuy Synthes) was charecterised using FTIR Spectroscopy, Scanning
Electron Microscopy (SEM) and Energy Dispersive X-ray spectroscopy
(EDX). Human mesenchymal stem cells (hMSC) isolated from bone
marrow aspirates of healthy donors were used for this study. Cytotox-
icity evaluation of the scaffold was performed as per the ISO standard
protocols of elution and direct contact. Biosel scaffold pre-treated with
100ug/ml ﬁbronectin (Millipore,USA) were seeded at a density of 1
million hMSCs / scaffold using a vacuum technique. Following a 3hr
incubation the scaffolds were transferred to a sterile non adherent 6
well plate (BD Biosciences) and maintained at 37 0C and 5% CO2 in a
humidiﬁed incubator. 48 hrs post seeding test scaffolds were induced
using standard osteogenic differentiation medium. Cell attachment and
cell viability over time was evaluated visually using the SEM.& confocal
microscope respectively. A two colour stain for simultaneous detection
of live/dead cells was used (Molecular Probes, Invitrogen). The protein
production on days 7 and 14was assayed by using the BCA Protein assay
kit (Pierce, USA).The matrices were incubated with 0.1% triton -X 100
and left overnight in a shaker at 40C. The cell lysate was analysed for
protein production and ALP activity.
Results: The SEM micrograph of HA/TCP Biosel scaffold exhibited crys-
tals characteristic of HA. The scaffolds consisted of pores of unequal size.
As seen from the graph EDX results indicate the presence of inorganic
elements like Ca and P, traces of Al, as well as C & O. The EDX result
indicates that Ca/P ratio of 2.30 is higher than that of pure HA (1.67) andTCP (1.5) and in 75%HA/25%TCP (1.65). The scaffold provides a non toxic
environment for hMSCs as depicted by insigniﬁcant differences in cell
viability between the control and treated conditions. SEM images showa
high cell density and show good matrix deposition on the scaffold sur-
face. Alsoviability of the cells on the scaffold surfacewas conﬁrmedusing
a live / dead stain and imaged using the Confocal Laser Scanning Electron
Microscope (CLSM). Protein production increased signiﬁcantly fromDay
7 to Day 14 on both control (hMSC) and osteogenically differentiated
scaffolds. However low levels of ALP Activity was detected.
Conclusions: The Biosel scaffold provides a safe, non-toxic environ-
ment for hMSC attachment, proliferation and matrix deposition. How-
ever, the osteoconductive properties of the scaffold is debatable as low
levels of alkaline phosphatase activity was detected. This could be
because of low cell numbers as evidenced by SEM images depicting
poor cell penetration at the scaffold interior. A 3-D perfusion bioreactor
system is now being tested to enhance ﬂuid ﬂow throughout the scaf-
fold and enhance bone tissue formation by the application of
mechanical stimulation.
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THE EFFECTS OF PENTOSAN POLYSULPHATE AND POLYSULPHATED
GLYCOSAMINOGLYCAN ON CHONDROGENIC DIFFERENTIATION OF
CANINE BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN
THREE-DIMENSIONAL ALGINATE CULTURES
E.C. Bwalya, II, S. Kim, J. Fang, S. Somarathne, K. Hosoya, M. Okumura.
Hokkaido Univ., Sapporo, Japan
Purpose: To determine the effects of pentosan polysulphate (PPS) and
polysulphated glycosaminoglycan (PSGAG) on chondrogenic differ-
entiation of Canine bone marrow-derived mesenchymal stem cells
(cBMSCs) in three-dimensional (3-D) alginate beads culture.
Methods: cBMSCswere isolated and cultured from three (3) young dogs
(Mean age: 11.5 months). Primary cultured cells were encapsulated in
alginate beads and cultured in the presence and absence of PPS or
PSGAG at concentrations of 1, 3 and 5 mg/mL for 20 days. The negative
control group was treated with 10% DMEM while the positive control
group was treated with 10% DMEM supplemented with 10 ng/mL por-
cine TGF-b1. PPS and PSGAG were supplemented at the indicated con-
centrations in a commercially prepared deﬁned chondrogenic
differentiation medium. Gene expression for chondrogenic differ-
entiation was analysed by RT-PCR gel electrophoresis and qPCR for;
type I collagen (Chondrocyte dedifferentiation), type X collagen
(Chondrocyte hypertrophy), HIF-2a, and for cartilage-speciﬁc genes;
Sox-9, type II collagen and aggrecan.
Results: PPS was effective at all concentrations in suppressing the
upregulation of type I collagen although no signiﬁcant difference was
observed within the treatment groups and relative to the negative
control. It also effectively inhibited the expression of type X collagen at
3 and 5 mg/mL although signiﬁcant difference was observed only
between the latter and the negative control. There was no signiﬁcant
difference in HIF-2a fold-changes in the relative gene expression
between the treatment groups although a slight upregulation was
observed at PPS concentration of 3 mg/mL. To the contrary, type I col-
lagen was signiﬁcantly upregulated (p < 0.05) at all PSGAG concen-
trations relative to the negative control. Type X collagen was
downregulated at concentrations of 1 and 3 mg/mL although signiﬁcant
difference (p < 0.05) was observed only between the former and neg-
ative control. HIF-2awas upregulated relative to the negative control at
all PSGAG concentrations although signiﬁcant difference (p < 0.05) was
observed only at 1 and 3 mg/mL relative to the negative control. Sox-9
gene expressionwas suppressed in all treatment groups and undetected
on RT-PCR gel electrophoresis. Type II collagen and aggrecan gene
expression were not upregulated by PPS relative to the negative control
although at 3 mg/mL a slight non-signiﬁcant upregulation of both genes
was observed. To the contrary, in the absence of Sox-9 gene expression,
type II collagen gene expression was upregulated at PSGAG concen-
trations of 3 and 5 mg/mL but signiﬁcant difference (p < 0.05) was
observed only between the latter and negative control. At PSGAG con-
centration of 1 mg/mL, type II collagen was signiﬁcantly downregulated
(p 0.05) within the treatment group in aggrecan gene expression
although 3 mg/mL PSGAG showed a slight upregulation while 1 and 5
mg/mL showed a downregulated gene expression relative to the neg-
ative control.
Conclusions: The effects of PPS and PSGAG may have distinct mecha-
nism of action on MSCs metabolism. While both showed inhibitory
